These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10376167)

  • 1. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
    Putnam GP; O'Quinn S; Bolden-Watson CP; Davis RL; Gutterman DL; Fox AW
    Cephalalgia; 1999 Sep; 19(7):668-75. PubMed ID: 10524661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hazards of medication refills by telephone.
    Solomon S
    Headache; 2002 Sep; 42(8):835. PubMed ID: 12390654
    [No Abstract]   [Full Text] [Related]  

  • 8. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.
    Visser WH; Jaspers NM; de Vriend RH; Ferrari MD
    Cephalalgia; 1996 Dec; 16(8):554-9. PubMed ID: 8980858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R
    Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract]   [Full Text] [Related]  

  • 10. Triptans and migraine.
    Bateman DN
    Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects.
    Boska MD; Welch KM; Schultz L; Nelson J
    Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 15. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence against strong correlation between chest symptoms and ischemic coronary changes after subcutaneous sumatriptan injection.
    Tomita M; Suzuki N; Igarashi H; Endo M; Sakai F
    Intern Med; 2002 Aug; 41(8):622-5. PubMed ID: 12211529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 19. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.